| Allovir, Inc. |
10%+ Owner |
Common Stock |
11,448,081 |
$115,348,575 |
$10.08 |
18 Mar 2025 |
By Samsara BioCapital, L.P. |
| Scholar Rock Holding Corp |
10%+ Owner |
Common Stock |
6,788,609 |
$108,133,716 |
$15.93 |
16 Oct 2023 |
By Samsara BioCapital, L.P. |
| Mineralys Therapeutics, Inc. |
10%+ Owner |
Common Stock |
5,674,916 |
$76,611,366 |
$13.50 |
13 Mar 2025 |
By Samsara BioCapital, L.P. |
| CARGO Therapeutics, Inc. |
10%+ Owner |
Common Stock |
4,415,689 |
$75,066,713 |
$17.00 |
30 May 2024 |
By Samsara BioCapital, L.P. |
| Neurogene Inc. |
10%+ Owner |
Common Stock |
1,717,127 |
$47,220,993 |
$27.50 |
26 Nov 2024 |
By Samsara BioCapital, L.P. |
| vTv Therapeutics Inc. |
10%+ Owner |
Pre- Funded Warrants (Right to Buy) |
892,578 |
$10,532,420 |
$11.80 |
05 Mar 2024 |
Samsara BioCapital, L.P. |
| vTv Therapeutics Inc. |
10%+ Owner |
Class A Common Stock |
206,784 |
$3,506,416 |
$16.96 |
05 Mar 2024 |
By Samsara BioCapital, L.P. |
| CARGO Therapeutics, Inc. |
10%+ Owner |
Series A-1 convertible preferred stock |
0 |
|
|
14 Nov 2023 |
By Samsara BioCapital, L.P. |
| CARGO Therapeutics, Inc. |
10%+ Owner |
Series A-2 convertible preferred stock |
0 |
|
|
14 Nov 2023 |
By Samsara BioCapital, L.P. |
| CARGO Therapeutics, Inc. |
10%+ Owner |
Series Seed convertible preferred stock |
0 |
|
|
14 Nov 2023 |
By Samsara BioCapital, L.P. |